Register Now

Welcome to Medical Device Playbook 2018
VANCOUVER

Medical Device Playbook, Canada’s premiere event for medical device professionalsis returning to the Vancouver Terminal City Club on May 23, 2018.

Industry speakers and panels from British Columbia and across North America will discuss what it takes to achieve this year’s theme: Dream a Bigger Dream. Network and learn 2018 trends, opportunities, and strategies. Entrepreneur Case Studies, Human Factors and Design, and Clinical/Regulatory advice from industry veterans.

Event includes Lunch, Breaks, and Networking Reception. All net proceeds will go to LifeSciences BC for future medtech initiatives.

Vancouver Speakers

  • MITCH LEVINSON, Co-Founder, President and CEO at Cerebrotech - San Francisco

    Serial Medtech entrepreneur and inventor of over 40 issued and numerous pending U.S. patents

    + Show Bio

    Cerebrotech: A company “designed” to survive an unforgiving financing environment

    Learn how I used an engineering approach to “design” my fledgling startup to survive.

  • VIRGINIA A. LANG, President and Chief Scientist, HirLan, Inc. and HirLan International SA - Carlsbad CA

    Human Factors Pioneer

    + Show Bio

    Human Factors is good business -- not an obstacle!

  • MIKE TOTTERMAN, CEO and co-founder of Clerio Vision - Rochester NY

    Co-founded iCardiac Technologies, and VirtualScopics; former principal at 3Com Ventures

    + Show Bio

    Strategic Partnering to Support Medical Device Development

    To speed market introduction and reduce capital intensity, it's critical to consider how to best partner to deliver basic science, product design and development, initial and scale manufacturing, pre-clinical and clinical development, regulatory approval, distribution, sales and service.

  • Kevin Strange, President and CEO at Biolux Research

    20 Year veteran of Vancouver Medical Device Start-ups

    + Show Bio

    My 20 years of Medical Device Start-ups in Vancouver

    All my ventures were excellent ideas / tech with great promise for improving patient’s lives. Each also had challenges common to start-ups.

  • MICHAEL HOEY, Co-Founder & Chief Technology Officer, NxThera - Minneapolis

    Expert in thermotherapy with 72 patents granted and 94 patents pending

    + Show Bio

    Are you limiting your platform's potential?

    Case study: Applying orthopaedics technology to urology

  • PAUL WEBER, President and Chief Executive Officer Perimeter Medical Imaging - Toronto

    Medical Device Marketing, International Distribution, and Business Development Expert

    + Show Bio

    Doing strategic partner deals

    Critical partnering considerations with case study illustration

  • DOUG GOERTZEN, CEO, Kardium - Vancouver

    Local SFU EE grad now leading Medtech start-up

    + Show Bio

    Kardium – The journey of transforming a naïve idea into a commercial medical device

    Exciting, frustrating, exhilarating, painful, and gratifying story of how the Kardium team created the most advanced therapeutic catheter ever.

  • SCOTT PHILLIPS, CEO, StarFish Medical - Victoria

    Creator Medical Device Playbook

    + Show Bio

    Dream a Bigger Dream

    What it takes to build a $100M Medical Device Product or Company

  • VESNA JANIC, Director of QA/RA StarFish Medical - Victoria

    QA/RA responsible for 30+ concurrent medical devices and companies

    + Show Bio

    Preparing for ISO 13485:2016

    Lessons from our recent audit

Location

Terminal City Club
837 W Hastings Street
Vancouver BC V6C 1B6
(604) 681-4121

2017 recap

The 2017 events in Toronto and Vancouver were a hit with 450+ participants, speakers, and sponsors. Veteran speakers providing industry insights and experience joined rooms full of the medical device entrepreneurs to exchange ideas and business cards in a day-long event designed specifically for local medtech innovators.

92% would recommend the event to friends

 “It is the only ‘conference’ of its type in Canada. I really enjoyed that it was all about the business and commercialization aspects of the health-tech industry and not heavily based on technology.”